卒中后二级预防药物的处方、启动与停用存在性别差异
女性出院时降压药处方(OR 0.82)、60天内启动降压药(OR 0.76)和抗血栓药(OR 0.89)均低于男性;总体停药无差异,但年龄交互显著,年轻女性和老年女性停药可能性更高。
要点
- 女性卒中后出院时降压药处方少于男性(OR 0.82)。
- 女性60天内启动降压药和抗血栓药少于男性(OR 0.76和0.89)。
- 总体停药无性别差异,但年龄交互显著,年轻和老年女性停药更多。
核心结论
- 卒中后二级预防药物在处方、启动和停用方面存在性别差异,且许多差异具有年龄特异性。
研究设计与样本
- 回顾性队列研究,使用澳大利亚卒中临床登记(42家医院,维多利亚和昆士兰,2012-2016年)的个人水平链接数据。
主要发现
- 女性出院时降压药处方低于男性(OR 0.82 [95% CI, 0.74-0.91])。
- 女性60天内启动降压药(OR 0.76 [95% CI, 0.69-0.84])和抗血栓药(OR 0.89 [95% CI, 0.82-0.96])低于男性。
- 总体停药无性别差异,但年龄交互显著(Pinteraction均<0.002),年轻女性(<45岁)和老年女性(>90岁)比同龄男性更可能停用二级预防药物。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Women less frequently receive secondary prevention medications at discharge poststroke than men. It is unclear whether similar sex differences exist in the long term poststroke, after accounting for age and clinical characteristics. We aimed to evaluate sex differences in medication prescription, initiation, and discontinuation poststroke or transient ischemic attack. METHODS: A retrospective cohort study using person-level linked data from the Australian Stroke Clinical Registry (42 hospitals; Victoria and Queensland; 2012-2016). We included all adults with first-ever ischemic stroke, intracerebral hemorrhage, or transient ischemic attack who survived >60 days post-discharge. For each major class of secondary prevention medication (antihypertensive, antithrombotic, or lipid lowering), we evaluated sex differences in prescription at hospital discharge, initiation within 60 days, and discontinuation within 2 years post-discharge. Sex differences were assessed using multivariable models, adjusted for sociodemographics and comorbidities. Where effect modification by age was found (Pinteraction≤0.05), age-specific odds ratios were reported. RESULTS: Among 8108 women (median age, 74.3 years) and 10 344 men (median age, 70.5 years) with first-ever stroke (≈8% intracerebral hemorrhage) or transient ischemic attack, women were less likely to be prescribed antihypertensive medications on discharge (odds ratio, 0.82 [95% CI, 0.74-0.91]). Women were less likely to initiate antihypertensive (odds ratio, 0.76 [95% CI, 0.69-0.84]) and antithrombotic (odds ratio, 0.89 [95% CI, 0.82-0.96]) medications within 60 days than men. While there was no overall difference in discontinuation between men and women, interactions were observed with age (Pinteraction, all <0.002). Younger women (aged <45 years) and older women (aged >90 years) were more likely to discontinue secondary prevention medications than men of equivalent age. CONCLUSIONS: Sex differences exist for prescription, initiation, and discontinuation of secondary prevention medications poststroke. With many sex differences being age specific, there is a critical need for targeted interventions to improve prevention medication use in these patient subgroups.
引用
- Dalli LL, Andrew NE, Olaiya MT, et al. Sex Differences in Prescription, Initiation, and Discontinuation of Secondary Prevention Medications After Stroke. Stroke. 2025. PMID: 40270283. doi:10.1161/STROKEAHA.124.050207
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。